Here’s an example of product adoption with zero reimbursement
At a recent medical device conference in San Francisco, a Medtronic executive gave an example of a device finding adoption even though the device is not reimbursed.
Medtech startups should look at ischemic stroke as area of unmet need
Medical device startups have a huge opportunity in developing devices to treat ischemic and even hemorrhagic stroke and stand to win reimbursement with good clinical and economic evidence.
At ViVE 2024, Panelists Share Prior Authorization Progress and Frustration in Payer Insights Program
At the Payer Insights sessions on Day 1 of ViVE 2024, a panel on prior authorization offered compelling insights from speakers who shared the positive developments in this area after years of mounting frustration. Speakers also shared challenges as they work with providers to figure out how policy developments and technology will work in practice.
Medtronic wins FDA nod to launch first MR-Conditional CRT pacemakers
Medtronic becomes the first in the U.S. to win FDA approval for a quadripolar cardiac resynchronization therapy pacemaker that is also safe to use under MRI if certain conditions are met.
Medtronic sans the medical supplies business means RIP widget maker
Medtronic is rumored to be selling its medical supplies business to Cardinal Health in shift to become a disease management company eager to play a role in the continuum of care as opposed to a widget maker.
Medtronic’s wearable vest brings noninvasive twist to cardiac mapping
Cardiac mapping has been an important tool to make ablations safe and effective, but it has required catheterization, unlike Medtronic's new product.
Medtronic finally hears call of Masimo CEO to share data
Medtronic CEO Omar Ishrak joins the board of Patient Safety Movement Foundation founded by Masimo CEO Joe Kiani and takes the pledge to share data, something Kiani had wanted for years.
Physician Targeting Using Real-time Data: How PurpleLab’s Alerts Can Help
By leveraging real-time data that offers unprecedented insights into physician behavior and patient outcomes, companies can gain a competitive advantage with prescribers. PurpleLab®, a healthcare analytics platform with one of the largest medical and pharmaceutical claims databases in the United States, recently announced the launch of Alerts which translates complex information into actionable insights, empowering companies to identify the right physicians to target, determine the most effective marketing strategies and ultimately improve patient care.
Partnerships key to success of value-based care in medtech
Partnerships between insurers, health systems and medtech companies as well as insight gleaned from Big Data are going to key to the success of value-based care in the medical devices industry.
FDA approves first artificial pancreas much sooner than expected
FDA approves the first automated insulin delivery system giving Medtronic the distinction of being the first in a category that is set to revolutionize daily disease management for type 1 diabetes patients.
Medtronic offers assurances as analysts question timeline for artificial pancreas
Medtronic launched a next-gen insulin pump in mid August, but analysts are more interested in when the FDA will approve the company's breakthrough device - the artificial pancreas.
Medtronic follows Dexcom to go the smartphone route with CGM
Medtronic is giving diabetes patients on insulin injection therapy outside the U.S. the ability to view blood glucose data from their continuous glucose monitors on their smartphones.
The Impact Brands: Empowering Wellness Through Natural and Holistic Solutions
In an era of escalating healthcare costs and a growing preference for natural, holistic approaches to health, The Impact Brands emerges as a collective of diverse brands dedicated to supporting overall wellness through natural means.
Morning Read: Unapproved stem cell tests abound, an artificial pancreas on the horizon
Also, Owlstone has spun out Owlstone Medical to develop a breathalyzer for clinical diagnostics to battle cancer and Pocket DNA sequencers will become ubiquitous, according to Dr. Eric Topol.
Medtronic seeks to manage heart failure from end to end
Medtronic wants to serve heart failure patients with moderate or severe symptoms with a mix of devices and services.
Morning Read: Medtronic buys HeartWare for $1.1B, SCOTUS denies Sequenom appeal on patent for DNA test
Also, out-of-pocket costs per hospitalization soar, AstraZeneca seeks to extend Crestor patent under the Orphan Drug Act and Virginia Mason's CEO decides to stay after all.
Medtronic moves into pre-diabetes programs with Canary Health deal
Medtronic will also work with Canary Health to develop programs that enlist Medtronic’s devices, services and infrastructure and Canary Health’s behavior change programs, design, and user engagement insights.
Medtronic allies with Qualcomm Life in quest for continuous glucose monitoring with smaller design, better data
A low-cost, connected continuous glucose monitor that can provide clinical decision support seems like it would be a nice addition to the toolset of Diabeter, a Danish operator of Diabetes clinics, which Medtronic acquired last year.